Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Cell-based treatments for chronic metabolic disorders such as diabetes are poised to disrupt conventional treatments based on insulin administration through needles. These treatments involve transplanting cells that can provide the needed hormone or enzyme directly into the patients’ circulation, in principle for years and without human intervention.
However, these transplanted cells need to be protected from immune recognition by the patients’ immune system. This project describes the optimization and testing of capsules that can provide physical immune isolation to such therapeutic transplanted cells, replacing the current requirement for chemical immune suppression.
These capsules can help bring Canadian and global cell-based therapies to the clinic, and potentially offers significant improvements to the quality of life for Canadian, and global, patients.
Sam Ros;Felix Gross;Zhen Hu;Leticia Hernandez Galan
Allarta Life Science Inc
Biochemistry / Molecular biology
Find the perfect opportunity to put your academic skills and knowledge into practice!Find Projects
The strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.